REFERENCES:
1. Abrams J (1989); “Transdermal nitroglycerin in angina pectoris”; European Heart Journal; 10(suppl_A); 11–19
2. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM and Moye LA (2004); “Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke”; The New England Journal of Medicine; 351(21); 2170-2178.
3. Belkacemi A, Agostoni P, Voskuil M, Doevendans P, Stella P (2011); “Drug-eluting Balloons in Coronary Artery Disease - Current and Future Perspectives”; ICR; 6(2); 157-160.
4. Degertekin M, Regar E, Tanabe K, Smits PC, van der Giessen WJ, Carlier SG, de Feyter P, Vos J, Foley DP, Ligthart JM (2003); “Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience”; J. Am. Coll. Cardiol.; 41(2); 184-189.
5. Di Mario C, Griffiths H, Goktekin O, Peeters N, Verbist J, Bosiers M, Deloose K, Heublein B, Rohde R, Kasese V, Ilsley C, Erbel R (2004); “Drug-eluting bioabsorbable magnesium stent”; Journal of Interventional Cardiology; 17(6); 391-395.
6. Duan J, Yu Y, Li Y, Yu Y, Sun Z (2013); “Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model”; Biomaterials; 34(23); 5853-5862.
7. Galagudza MM, Korolev DV, Sonin DL, Postnov VN, Papayan GV, Uskov IS, Belozertseva AV, Shlyakhto EV (2010); “Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: Surface functionalization, natural biodistribution, and acute toxicity”; Int. J. Nanomed.; 5; 231-237
8. Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR (1996); “Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers”; Proc. Natl. Acad. Sci.; 93(10); 4897-4902.
9. Lincoff AM, Furst JG, Ellis SG, Tuch RJ, Topol EJ (1997); “Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model”; J. Am. Coll. Cardiol.; 29(4); 808-816.
10. Matoba T, Koga JI, Nakano K, Egashira K, Tsutsui H (2017); “Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular disease”; J Cardiol.; 70(3); 206-211.
11. Paulis LE, Geelen T, Kuhlmann MT, Coolen BF, Schafers M, Nicolay K, Strijkers GJ (2012); “Distribution of lipid-based nanoparticles to infarcted myocardium with potential application for MRI monitored drug delivery”; J. Con.Rel; 162(2); 276-285
12. Perel P., Avezum A., Huffman M., Pais P., Rodgers A., Vedanthan R., Wood D., Yusuf S (2015); “Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease”; Glob Heart;10(2); 99-110.
13. Qiao Y. et al.(2017); “PEG coated gold nanoparticles attenuate β adrenergic receptor mediated cardiac hypertrophy”; Int. J Nanomed; 12; 4709-4719.
14. Richelsen RKB, Overvad TF, Jensen SE (2016); “Drug-Eluting Balloons in the Treatment of Coronary De Novo Lesions: A Comprehensive Review”; Cardiol Ther; 5(2); 133-160
15. Rosenschein U, Roth A, Rassin T, Basan S, Laniado S, Miller HI (1997); “Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE trial) results of the feasibility phase”; Circulation; 95(6); 1411-1416.
16. Stone GW, Ellis SG, Cox DA, Hermiller J, Shaughnessy CO, Mann JT, Turco M, Caputo R, Bergin P, and Greenberg J (2004); “A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease”; N. Engl. J. Med.; 350(3); 221-231.
17. Takahama H, Minamino T, Asanuma H, Fujita M, Asai T, Wakeno M, Sasaki H, Kikuchi H, Hashimoto K, Oku N (2009); “Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats”; J. Am. Coll.Cardiol. ; 53(8); 709-717
18. Tang Y, Gan X, Cheheltani R et al. (2014); “Targeted delivery of vascular endothelial growth factor improves stem cell therapy in a rat myocardial infarction model”; Nanomedicine; 10(8); 1711-1718.
19. Virmani R, Farb A, Guagliumi G, Kolodgie FD (2004); “Drug eluting stents: Caution and concerns for long-term outcome”; Coron.Artery Dis.; 15(6); 313-318.
20. Waksman R and Pakala R (2009); “Drug-Eluting Balloon: The Comeback Kid?”; Circ Cardiovasc Interv.; 2(4); 352-358.
21. Wang Y, Bai Y, Price C, Boros P, Qin L, Bielinska AU, Kukowska-Latallo JF, Baker JR, Bromberg JS (2001); “Combination of electroporation and DNA/dendrimer complexes enhances gene transfer into murine cardiac transplants”; Am. J. Transplantation; 2001; 1(4);334-338.
22. Wieneke H, Dirsch O, Sawitowski T, Gu YL, Brauer H, Dahmen U, Fischer A, Wnendt S, Erbel R (2003); “Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits”; Cathet. Cardiovasc. Interv.; 60(3); 399-407.
23. Wissgott C, Richter A, Kamusella P, Steinkamp HJ (2007); “Treatment of critical limb ischemia using ultrasound-enhanced thrombolysis (PARES Trial): Final results”. J. Endovasc. Ther.; 14(4); 438-443.
24. Wu Y, Unger EC, McCreery TP, Sweitzer RH, Shen D, Wu G, Vielhauer MD (1998); “Binding and lysing of blood clots using MRX-408”; Invest. Radiol.; 33(12); 880-885.
25. Xingyan L, Hong L, Zhaowu Z, Weihua Z, Jianqiang L, Zhiwei H (2011); “Pharmacokinetics of ligustrazine ethosome patch in rats and anti-myocardial ischemia and anti-ischemic reperfusion injury effect”; Int J Nanomed.; 6; 1391–1398.
.png)
